Skip to main content

Find Clinical Trials

Home
Conditions
Recurrent Acute Myeloid Leukemia

Clinical trial condition

Recurrent Acute Myeloid Leukemia

Explore clinical trials studying Recurrent Acute Myeloid Leukemia. Study availability and eligibility vary by location and protocol.

79 public trials 32 recruiting studies

Refine in advanced search Browse all conditions

Recurrent Acute Myeloid Leukemia trial results

Completed

Natural Killer Cells Before and After Donor Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia

NCT01904136

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Acute Myeloid Leukemia With Gene Mutations, +26 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

8-Chloroadenosine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

NCT02509546

Conditions: Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Hematologic Diseases, Hemic and Lymphatic Diseases, +7 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Completed

Pinometostat and Azacitidine in Treating Patients With Relapsed, Refractory, or Newly Diagnosed Acute Myeloid Leukemia With 11q23 Rearrangement

NCT03701295

Conditions: Acute Myeloid Leukemia With t(9;11)(p21.3;q23.3); MLLT3-MLL, Hematologic Diseases, Hemic and Lymphatic Diseases, +8 more
Locations: Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Completed

Prexasertib (LY2606368), Cytarabine, and Fludarabine in Patients With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

NCT02649764

Conditions: Bone Marrow Diseases, Chronic Disease, Chronic Myelomonocytic Leukemia, +16 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

OX40, Venetoclax, Avelumab, Glasdegib, Gemtuzumab Ozogamicin, and Azacitidine in Relapsed or Refractory Acute Myeloid Leukemia

NCT03390296

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +6 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Salsalate, Venetoclax, and Decitabine or Azacitidine for the Treatment of Acute Myeloid Leukemia or Advanced Myelodysplasia/Myeloproliferative Disease

NCT04146038

Conditions: Acute Myeloid Leukemia, Bone Marrow Diseases, Chronic Disease, +21 more
Locations: Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States

View Trial Details

Completed

High Throughput Drug Sensitivity Assay and Genomics- Guided Treatment of Patients With Relapsed or Refractory Acute Leukemia

NCT02551718

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +17 more
Locations: Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Completed

Fludarabine Phosphate, Clofarabine, and Busulfan With Vorinostat in Treating Patients With Acute Leukemia in Remission or Relapse Undergoing Donor Stem Cell Transplant

NCT02083250

Conditions: Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission, Allogeneic Hematopoietic Stem Cell Transplantation Recipient, +19 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Early Allogeneic Hematopoietic Cell Transplantation in Treating Patients With Relapsed or Refractory High-Grade Myeloid Neoplasms

NCT02756572

Conditions: Blasts 10 Percent or More of Bone Marrow Nucleated Cells, Bone Marrow Diseases, Chronic Myelomonocytic Leukemia-2, +15 more
Locations: Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Completed

Ipilimumab or Nivolumab in Treating Patients With Relapsed Hematologic Malignancies After Donor Stem Cell Transplant

NCT01822509

Conditions: Allogeneic Hematopoietic Stem Cell Transplant Recipient, Blood Protein Disorders, Bone Marrow Diseases, +44 more
Locations: City of Hope Comprehensive Cancer Center Duarte, California, United States

UC San Diego Moores Cancer Center La Jolla, California, United States

City of Hope South Pasadena South Pasadena, California, United States

Colorado Blood Cancer Institute Denver, Colorado, United States

View all 13 locations

View Trial Details